Article
rs8099917 and viral genotyping as indications for living donor liver transplantation for hepatitis C: a case report.
Transplantation proceedings - 1 Sept 2014
Yoshida Y, Ikegami T, Yoshizumi T, Toshima T, Yamashita Y-I, Yoshiya S, Shirabe K, Maehara Y
Abstract excerpt
INTRODUCTION: Appropriate antiviral treatment is essential for living donor liver transplantation (LDLT) to be effective for treating hepatitis C. However, it has never been reported that pre-LDLT genetic analyses of both host and virus, with prediction of the outcome of post-LDLT antiviral treatment, indicated LDLT for a borderline case. CASE REPORT: We have reported the case of a 68-year-old woman with liver...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
